Constitutive expression of the ATP-binding cassette transporter ABCG2 enhances the growth potential of early human hematopoietic progenitors

Stem Cells

Volumn 26, Issue 3, 2008, Pages 810-818

  Ahmed, Farid ^a,b   Arseni, Natalia ^a,b   Glimm, Hanno ^c   Hiddemann, Wolfgang ^a,b   Buske, Christian ^a,b   Feuring Buske, Michaela ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

ABCG2; Hematopoiesis; Human progenitor cells

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CD19 ANTIGEN; CD34 ANTIGEN; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; HYBRID PROTEIN; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; COLONY FORMING CELL; ERYTHROID CELL; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MACROPHAGE; MEGAKARYOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; UMBILICAL CORD; ANIMAL; B LYMPHOCYTE; BONE MARROW CELL; CELL CLONE; CELL DIFFERENTIATION; CELL STRAIN K 562; CLONOGENIC ASSAY; COCULTURE; CYTOLOGY; FETUS BLOOD; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; MOUSE MUTANT; RETROVIRUS;

MUS;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CLONE CELLS; COCULTURE TECHNIQUES; COLONY-FORMING UNITS ASSAY; FETAL BLOOD; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; K562 CELLS; MICE; MICE, SCID; MYELOID CELLS; NEOPLASM PROTEINS; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; TRANSDUCTION, GENETIC;

EID: 43049116567     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0527     Document Type: Article

References (35)

1. Weissman IL, Anderson DJ, Gage F. Stem and progenitor cells: Origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol 2001;17:387-403.
2. Zhou S, Schuetz JD, Bunting KD et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001;7:1028-1034.
3. Goodell MA, Brose K, Paradis G et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996;183:1797-1806.
4. Challen GA, Bertoncello I, Deane JA et al. Kidney side population reveals multilineage potential and renal functional capacity but also cellular heterogeneity. J Am Soc Nephrol 2006;17:1896-1912.
5. Chen J, Hersmus N, Van Duppen V et al. The adult pituitary contains a cell population displaying stem/progenitor cell and early embryonic characteristics. Endocrinology 2005;146:3985-3998.
6. Kawanabe N, Murakami K, Takano-Yamamoto T. The presence of ABCG2-dependent side population cells in human periodontal ligaments. Biochem Biophys Res Commun 2006;344:1278-1283.
7. Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002;99:507-512.
8. Zhou S, Morris JJ, Barnes Y et al. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc Natl Acad Sci U S A 2002;99:12339-12344.
9. Suvannasankha A, Minderman H, O'Loughlin KL et al. Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: Frequent expression and possible correlation with shorter disease-free survival. Br J Haematol 2004;127:392-398.
10. Uggla B, Stahl E, Wagsater D et al. BCRP mRNA expression v. clinical outcome in 40 adult AML patients. Leuk Res 2005;29:141-146.
11. Steinbach D, Sell W, Voigt A et al. BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia. Leukemia 2002;16:1443-1447.
12. van den Heuvel-Eibrink MM, van der Holt B, Burnett AK et al. CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age. Ann Hematol 2007;86:329-337.
13. van den Heuvel-Eibrink MM, Wiemer EA, Prins A et al. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML). Leukemia 2002;16:833-839.
14. Damiani D, Tiribelli M, Calistri E et al. The prognostic value of P-glycoprotein (ABCB) and breast cancer resistance protein (ABCG2) in adults with de novo acute myeloid leukemia with normal karyotype. Haematologica 2006;91:825-828.
15. Jordanides NE, Jorgensen HG, Holyoake TL et al. Functional ABCG2 is overexpressed on primary CML CD34+ cells and is inhibited by imatinib mesylate. Blood 2006;108:1370-1373.
16. Feuring-Buske M, Hogge DE. Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia. Blood 2001;97:3882-3889.
17. Mickisch GH, Merlino GT, Galski H et al. Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance. Proc Natl Acad Sci U S A 1991;88:547-551.
18. Bunting KD, Galipeau J, Topham D et al. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood 1998;92:2269-2279.
19. Bunting KD, Zhou S, Lu T et al. Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo. Blood 2000;96:902-909.
20. Modlich U, Kustikova OS, Schmidt M et al. Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis. Blood 2005;105:4235-4246.
21. Bozorgmehr F, Laufs S, Sellers SE et al. No evidence of clonal dominance in primates up to 4 years following transplantation of multidrug resistance 1 retrovirally transduced long-term repopulating cells. STEM CELLS 2007;25:2610-2618.
22. Sellers SE, Tisdale JF, Agricola BA et al. The effect of multidrug-resistance 1 gene versus neo transduction on ex vivo and in vivo expansion of rhesus macaque hematopoietic repopulating cells. Blood 2001;97:1888-1891.
23. Buske C, Feuring-Buske M, Antonchuk J et al. Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo. Blood 2001;97:2286-2292.
24. Buske C, Feuring-Buske M, Abramovich C et al. Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cells. Blood 2002;100:862-868.
25. Hogge DE, Lansdorp PM, Reid D et al. Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor. Blood 1996;88:3765-3773.
26. Uchida N, Fujisaki T, Eaves AC et al. Transplantable hematopoietic stem cells in human fetal liver have a CD34(+) side population (SP) phenotype. J Clin Invest 2001;108:1071-1077.
27. Patrawala L, Calhoun T, Schneider-Broussard R et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2-cancer cells are similarly tumorigenic. Cancer Res 2005;65:6207-6219.
28. Ueda T, Brenner S, Malech HL et al. Cloning and functional analysis of the rhesus macaque ABCG2 gene. Forced expression confers an SP phenotype among hematopoietic stem cell progeny in vivo. J Biol Chem 2005;280:991-998.
29. Zhou S, Zong Y, Ney PA et al. Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels. Blood 2005;105:2571-2576.
30. Tonnelle C, Bardin F, Maroc C et al. Forced expression of the Ikaros 6 isoform in human placental blood CD34(+) cells impairs their ability to differentiate toward the B-lymphoid lineage. Blood 2001;98:2673-2680.
31. Conneally E, Cashman J, Petzer A et al. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabeticscid/scid mice. Proc Natl Acad Sci U S A 1997;94:9836-9841.
32. Parmar K, Mauch P, Vergilio JA et al. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci U S A 2007;104:5431-5436.
33. Adelman DM, Maltepe E, Simon MC. Multilineage embryonic hematopoiesis requires hypoxic ARNT activity. Genes Dev 1999;13:2478-2483.
34. Krishnamurthy P, Ross DD, Nakanishi T et al. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem 2004;279:24218-24225.
35. Krishnamurthy P, Schuetz JD. Role of ABCG2/BCRP in biology and medicine. Annu Rev Pharmacol Toxicol 2006;46:381-410.